GPT and neoplasm: Other covariates evaluated, including age, race, Japanese ethnicity, geographic region, eGFR, alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, total bilirubin levels, total protein, hepatic function based on NCI-ODWG, lactate dehydrogenase, ECOG performance status, tumor size, tumor type, FGFR2b status, prior gastrectomy, and administration of a single dose of mFOLFOX6 prior to randomization did not show a statistically significant impact on the PK of bemarituzumab.